FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin(® )added to standard therapy in patients with lung cancer

por Griffiths, Gareth O, Burns, Sarah, Noble, Simon I, Macbeth, Fergus R, Cohen, David, Maughan, Timothy S
Publicado 2009